Tolerability and pharmacokinetics of single and multiple ascending doses of GS 5816, with or without food, in volunteers
Latest Information Update: 17 Feb 2017
Price :
$35 *
At a glance
- Drugs Velpatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Gilead Sciences
- 13 Feb 2017 Results preclinical and clinical pharmacokinetics, safety, tolerability, published in the Antimicrobial Agents and Chemotherapy
- 05 May 2013 New trial record
- 28 Apr 2013 Results for the single and multiple dose cohorts presented at the 48th Annual Meeting of the European Association for the Study of the Liver.